Michael H. Augenbraun, MD

Upon graduation of medical school at the University of Rochester, Dr. Augenbraun pursued his residency at North Shore University Hospital and Infectious Diseases fellowship at SUNY Downstate. He is currently the Director of the Division of Infectious Diseases and Fellowship Program Director at SUNY Downstate/Kings County. He is also Professor of Medicine and of Epidemiology at SUNY Downstate, and Vice Chairman for the Department of Internal Medicine. His professional and research interests include sexually transmitted infections, HIV, hospital epidemiology, and history of medicine.

Research Interests:

STDs, Syphilis, Herpes, Hepatitis C, HIV

Current projects:

Resistant HSV, Syphilis, vaginitis, hepatitis C, hospital acquired infections

Education and Training:

• BA: History University of Rochester 1981
• MD: University of Rochester 1985
• Internal Medicine Residency: North Shore University Hospital/Memorial Sloan-Kettering Cancer Center 1988
• Infectious Diseases Fellowship: SUNY Downstate College of Medicine 1990

Mailing Address:
SUNY Downstate College of Medicine
450 Clarkson Avenue, MSC 56
Brooklyn, New York 11203

• A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. Edwards JE Jr, Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, Holmberg T, Cooke MT, Hoover K, Edwards L, Jacobs M, Sussman S, Augenbraun M, Drusano M, Yeaman MR, Ibrahim AS, Filler SG, Hennessey JP Jr. Clin Infect Dis. 2018 Apr 25. doi: 10.1093/cid/ciy185. [Epub ahead of print]
• Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing. Kamboj M, Brite J, Aslam A, Kennington J, Babady NE, Calfee D, Furuya Y, Chen D, Augenbraun M, Ostrowsky B, Patel G, Mircescu M, Kak V, Tuma R, Karre TA, Fry DA, Duhaney YP, Moyer A, Mitchell D, Cantu S, Hsieh C, Warren N, Martin S, Willson J, Dickman J, Knight J, Delahanty K, Flood A, Harrington J, Korenstein D, Eagan J, Sepkowitz K. Emerg Infect Dis. 2018 Mar;24(3):584-587. doi: 10.3201/eid2403.170961.
• Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy. Willis SJ, Cole SR, Westreich D, Edmonds A, Hurt CB, Albrecht S, Anastos K, Augenbraun M, Fischl M, French AL, Kalapila AG, Karim R, Peters MG, Plankey M, Seaberg EC, Tien PC, Adimora AA. AIDS. 2018 Mar 13;32(5):653-661. doi: 10.1097/QAD.0000000000001745
• Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study. French AL, Martin JW, Evans CT, Peters M, Kessaye SG, Nowicki M, Kuniholm M, Golub E, Augenbraun M, Desai SN; WIHS.J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):438-444. doi: 
• Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study. Kelly EM, Dodge JL, Bacchetti P, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters MG.Clin Infect Dis. 2017 Nov 29;65(12):2050-2056. doi: 10.1093/cid/cix716.